Archived Facts

Pain Therapeutics Inc. on Wednesday reported a bigger second-quarter loss as revenue declined from development partnerships for its lead drug candidate, the pain treatment Remoxy.

View full post on All News, Video and Posts related to SECTOR: Health Care

Popular Posts:

Related Posts:

Leave a Reply